Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alkermes Plc (NASDAQ:ALKS)

46.13
Delayed Data
As of May 27
 +1.84 / +4.15%
Today’s Change
27.14
Today|||52-Week Range
80.71
-41.89%
Year-to-Date
Alkermes Begins Phase I Study on Immuno-Oncology Drug
May 26 / Zacks.com - Paid Partner Content